Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA)Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era
News | Heart Failure | June 30, 2020
June 30, 2020 —  BioCardia, Inc. announced that the company has resumed cases in the CardiAMP Heart Failure Trial. The...
Signs for "Heroes work here" outside healthcare facilities and even the homes of clinicians have popped up across the country. This photo shows healthcare workers at the Lenox Health emergency room entrance being greeted to cheers and thanks for their essential service during the COVID-19 pandemic in New York City at a public thank you event May 21, 2020. #COVID19 #SARScov2 #pandemic #LenoxHill 

Signs for "Heroes work here" outside healthcare facilities and even the homes of clinicians have popped up across the country. This photo shows healthcare workers at the Lenox Hill emergency room entrance being greeted to cheers and thanks for their essential service during the COVID-19 pandemic in New York City at a public thank you event May 21, 2020.

Blog | Coronavirus (COVID-19) | June 22, 2020
Prior to January 2020 when clinicians read about the history of the 1918 flu, and epidemiologists predicted we were...
The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. FDA says hydroxychloroquine does not work to treat COVID-19.Getty Images #COVID19 #COVID19update #SARSCoV2

The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. Getty Images 

Feature | Coronavirus (COVID-19) | June 15, 2020 | Dave Fornell, Editor
June 15, 2020 — The U.S. Food and Drug Administration (FDA) today revoked the emergency use authorization (EUA) that...
The temporary COVID-19 hospital at the McCormick Place convention center in Chicago being toured by Illinois Gov. J.B. Pritzker April 3. The hospitals beds are set up in at least two of the expo halls, included two used the for annual RSNA radiology meeting in November each year. Photo by Susan Blair, U.S. Army Corps of Engineers, Chicago District

The temporary COVID-19 hospital at the McCormick Place convention center in Chicago being toured by Illinois Gov. J.B. Pritzker April 3. The hospitals beds are set up in at least two of the expo halls, included two used the for annual RSNA radiology meeting in November each year. Photo by Susan Blair, U.S. Army Corps of Engineers, Chicago District

Feature | Coronavirus (COVID-19) | April 28, 2020 | Dave Fornell, Editor
(UPDATED information added to this article June 10, 2020) April 28, 2020 — Medical conferences are where the latest...
Centricity Cardio Enterprise[1] is an integrated Cardiovascular PACS (CVPACS) and Information System (CVIS) that bridges the gaps between care areas and healthcare information systems. You get a single point of access for patient data, wave forms, images, analysis tools and physician reports – combined with powerful end-to-end management, analytics and workflow tools across the cardiovascular care pathway.
Webinar | Coronavirus (COVID-19) | June 10, 2020
The financial burden of COVID-19 has put tremendous pressure on health systems across the country. This webinar will...
A PCR genetic test nasal swab being taken from a patient to test if they are infected with COVID-19. While used as the primary test to diagnose coronavirus, up to 20 percent of patients will test negative even eight days after infection. Getty Images

A PCR genetic test nasal swab being taken from a patient to test if they are infected with COVID-19. While used as the primary test to diagnose coronavirus, up to 20 percent of patients will test negative even eight days after infection. Getty Images

News | Coronavirus (COVID-19) | June 10, 2020
June 10, 2020 — In a new study, Johns Hopkins researchers found that testing people for SARS-CoV-2 (COVID-19) too early...
Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH).

Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH). Novel coronavirus has turned out to have a sizable amount of cardiovascular involvement.

Feature | Coronavirus (COVID-19) | June 05, 2020 | Dave Fornell, Editor
It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but as larger...
All coronavirus content continued as the most popular content in May 2020. Two of the major topics included an article on the new Kawasaki-like inflammatory disease that affects children with COVID-19 and articles and videos on the cardiovascular effects of hydroxychloroquine in treating or preventing COVID. #COVID19 #SARScov2

All coronavirus content continued as the most popular content in May 2020. Two of the major topics included an article on the new Kawasaki-like inflammatory disease that affects children with COVID-19 and articles and videos on the cardiovascular effects of hydroxychloroquine in treating or preventing COVID. Find more cardiology related COVID-19 content.

Feature | June 04, 2020 | Dave Fornell, Editor
June 4, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2
Feature | Cardiovascular Business | June 03, 2020
The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework...
This is Figure 2 from the article in Radiology: Acute encephalopathy. A 60 year-old-man without history of seizures presenting with convulsion. (A-B) Multifocal areas of FLAIR hyperintensity in the right cerebellum (arrows in A), left anterior cingular cortex and superior frontal gyrus (arrows in B). (C-D) Restricted diffusion in the left anterior cingulate cortex, superior frontal and middle temporal gyrus (arrows in D) and right cerebellum (arrows in E), consistent with cerebellar diaschisis. #COVID19

This is Figure 2 from the article in Radiology: Acute encephalopathy. A 60 year-old-man without history of seizures presenting with convulsion. (A-B) Multifocal areas of FLAIR hyperintensity in the right cerebellum (arrows in A), left anterior cingular cortex and superior frontal gyrus (arrows in B). (C-D) Restricted diffusion in the left anterior cingulate cortex, superior frontal and middle temporal gyrus (arrows in D) and right cerebellum (arrows in E), consistent with cerebellar diaschisis. F) No hemosiderin deposits in gradient echo sequences.

Feature | Coronavirus (COVID-19) | June 02, 2020
June 2, 2020 — Four recent radiology studies, from New York, Italy, Iran and China, show how COVID-19 (SARS-CoV-2)...
he U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Abiomed Impella RP catheter-based heart pump to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism (PE).  #COVID19 #SARScov2
Feature | Coronavirus (COVID-19) | June 01, 2020
June 1, 2020 — The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the...
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
News | Coronavirus (COVID-19) | June 01, 2020
June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to an...
New Data Confirms Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19. Physio-Control LifePak defibrillator monitor.
Feature | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — As states begin to re-open as the number of COVID-19 patients declines, 40 percent of Americans still...
Videos | Coronavirus (COVID-19) | May 29, 2020
Jay Mohan, D.O., RPVI, interventional cardiology fellow at William Beaumont Hospital, Royal Oak, Michigan, created this...